Alpha 2.0
Login Register
» Articles » PMID: 30443286

Mutant Molecular Chaperone Activates Cytokine Receptor As a Homomultimer

Overview
Journal Oncotarget
Specialty Oncology
Date 2018 Nov 17
PMID 30443286
Citations 3
Authors
Marito Araki
Norio Komatsu
Affiliations
Soon will be listed here.
Citing Articles

The therapeutic mavericks: Potent immunomodulating chaperones capable of treating human diseases.

Eggleton P, De Alba J, Weinreich M, Calias P, Foulkes R, Corrigall V J Cell Mol Med. 2023; 27(3):322-339.

PMID: 36651415 PMC: 9889696. DOI: 10.1111/jcmm.17669.

Mechanism underlying the development of myeloproliferative neoplasms through mutant calreticulin.

Edahiro Y, Araki M, Komatsu N Cancer Sci. 2020; 111(8):2682-2688.

PMID: 32462673 PMC: 7419020. DOI: 10.1111/cas.14503.

The role of calreticulin mutations in myeloproliferative neoplasms.

Araki M, Komatsu N Int J Hematol. 2019; 111(2):200-205.

PMID: 31848992 DOI: 10.1007/s12185-019-02800-0.

References
1.
Araki M, Yang Y, Masubuchi N, Hironaka Y, Takei H, Morishita S . Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms. Blood. 2016; 127(10):1307-16. DOI: 10.1182/blood-2015-09-671172. View
2.
Marty C, Pecquet C, Nivarthi H, El-Khoury M, Chachoua I, Tulliez M . Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis. Blood. 2015; 127(10):1317-24. DOI: 10.1182/blood-2015-11-679571. View
3.
Syed R, Reid S, Li C, Cheetham J, Aoki K, Liu B . Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature. 1998; 395(6701):511-6. DOI: 10.1038/26773. View
4.
Araki M, Komatsu N . Novel molecular mechanism of cellular transformation by a mutant molecular chaperone in myeloproliferative neoplasms. Cancer Sci. 2017; 108(10):1907-1912. PMC: 5623763. DOI: 10.1111/cas.13327. View
5.
Elf S, Abdelfattah N, Chen E, Perales-Paton J, Rosen E, Ko A . Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation. Cancer Discov. 2016; 6(4):368-81. PMC: 4851866. DOI: 10.1158/2159-8290.CD-15-1434. View